Skip to Main Content

Good morning, everyone, and how are you today? We are doing just fine, thanks to a warm and shiny sun that is topped off by a deliciously cool breeze wafting about the Pharmalot campus. Although the world appears to have gotten off to a slow start this morning, we are busy as ever, foraging for interesting items and plotting our next moves. Perhaps you can relate. In any event, here are some tidbits to help you along. So good luck with your journey and do drop us a line when something fascinating or juicy or revealing pops up. …

An injectable drug that Pfizer (PFE) says is too dangerous to use along the spine is growing in popularity for back pain as doctors turn away from opioids. Although Depo-Medrol is approved for injecting into muscles and joints, doctors often inject the medicine close to the spinal cord for painful backs and necks. But the drug generated hundreds of complaints about injuries and complications, and while the company asked the Food and Drug Administration to ban that type of treatment five years ago, the request was never made public, The New York Times explains.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!